SCHEMBL7535289

SCHEMBL7535289

COc1ccc(OC)c(S(=O)(=O)N(C)c2ccc(Cl)cc2)c1

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
TSHR P16473 2/20 0.54
LMNA P02545 1/20 0.54
TP53 P04637 2/20 0.51
NR2F2 P24468 1/20 0.49
RAB9A P51151 1/20 0.49
PGR P06401 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
MAPT P10636 4/20 0.48
THRB P10828 1/20 0.48
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
NPSR1 Q6W5P4 2/20 0.47
HTT P42858 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KDM4E B2RXH2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6534758 0.82 KDM4E (0.69) ALDH1A1TSHRTP53RAB9APGR
SCHEMBL18545995 0.81 TSHR (0.58) ALDH1A1TSHRPGRL3MBTL1MAPT
SCHEMBL15480593 0.80 ALDH1A1 (0.53) ALDH1A1TSHRLMNATP53RAB9A
SCHEMBL18546037 0.80 PGR (0.51) ALDH1A1TSHRLMNAPGRL3MBTL1
SCHEMBL8602441 0.79 L3MBTL1 (0.60) ALDH1A1TSHRLMNATP53L3MBTL1
SCHEMBL6534675 0.78 PGR (0.71) ALDH1A1TP53NR2F2RAB9APGR
SCHEMBL15953603 0.77 SIRT2 (0.60) LMNANR2F2RAB9AMAPTSMN1; SMN2
SCHEMBL15212140 0.74 ALPL (0.62) LMNAPGRMAPTSMN1; SMN2
SCHEMBL7529463 0.73 TP53 (0.80) ALDH1A1LMNATP53L3MBTL1KMT2A
SCHEMBL407215 0.72 L3MBTL1 (0.64) ALDH1A1LMNATP53L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020183393-A1 Inhibitors of Rho C ICONIX PHARMACEUTICALS INC. 2002-12-05 US disclosed
WO-2002022565-A1 INHIBITORS OF RHO C ICONIX PHARMACEUTICALS, INC. (US) 2002-03-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183393-A1 Inhibitors of Rho C RHOC, ROCK1, RHOA ALDH1A1 3776/4885TSHR 488/4885LMNA 2037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.